Yield10 Bioscience Statistics
Share Statistics
Yield10 Bioscience has 1.03M
shares outstanding. The number of shares has increased by 60.47%
in one year.
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | 60.47% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 19.14% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 745 |
| FTD / Avg. Volume | 14.63% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.13 and the forward
PE ratio is null.
Yield10 Bioscience's PEG ratio is
0.
| PE Ratio | -0.13 |
| Forward PE | n/a |
| PS Ratio | 31.67 |
| Forward PS | n/a |
| PB Ratio | -0.77 |
| P/FCF Ratio | -0.19 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Yield10 Bioscience has an Enterprise Value (EV) of 4.04M.
| EV / Sales | 67.29 |
| EV / EBITDA | -0.29 |
| EV / EBIT | -0.4 |
| EV / FCF | -0.4 |
Financial Position
The company has a current ratio of 0.29,
with a Debt / Equity ratio of -0.88.
| Current Ratio | 0.29 |
| Quick Ratio | 0.29 |
| Debt / Equity | -0.88 |
| Debt / EBITDA | -0.23 |
| Debt / FCF | -0.32 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 582.16% and Return on Invested Capital is 4988.58%.
| Return on Equity | 582.16% |
| Return on Assets | -369.98% |
| Return on Invested Capital | 4988.58% |
| Revenue Per Employee | $2,068.97 |
| Profits Per Employee | $-498,448.28 |
| Employee Count | 29 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -93.96% in the
last 52 weeks. The beta is 1.43, so Yield10 Bioscience's
price volatility has been higher than the market average.
| Beta | 1.43 |
| 52-Week Price Change | -93.96% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 1.85 |
| Relative Strength Index (RSI) | 26.54 |
| Average Volume (20 Days) | 5,094 |
Income Statement
In the last 12 months, Yield10 Bioscience had revenue of 60K
and earned -14.46M
in profits. Earnings per share was -43.66.
| Revenue | 60K |
| Gross Profit | -230K |
| Operating Income | -14.42M |
| Net Income | -14.46M |
| EBITDA | -14.13M |
| EBIT | -14.42M |
| Earnings Per Share (EPS) | -43.66 |
Full Income StatementBalance Sheet
The company has 1.07M in cash and 3.21M in
debt, giving a net cash position of -2.14M.
| Cash & Cash Equivalents | 1.07M |
| Total Debt | 3.21M |
| Net Cash | -2.14M |
| Retained Earnings | -414.15M |
| Total Assets | 2.97M |
| Working Capital | -6.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -10.07M
and capital expenditures -46K, giving a free cash flow of -10.11M.
| Operating Cash Flow | -10.07M |
| Capital Expenditures | -46K |
| Free Cash Flow | -10.11M |
| FCF Per Share | -30.55 |
Full Cash Flow StatementMargins
Gross margin is -383.33%, with operating and profit margins of -24028.33% and -24091.67%.
| Gross Margin | -383.33% |
| Operating Margin | -24028.33% |
| Pretax Margin | -24091.67% |
| Profit Margin | -24091.67% |
| EBITDA Margin | -23545% |
| EBIT Margin | -24028.33% |
| FCF Margin | -16856.67% |
